31 – 40 of 175
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2020
- Immune cells as tumor drug delivery vehicles (2020) JOURNAL OF CONTROLLED RELEASE. 327. p.70-87
- Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine (2020) bioRxiv.
- Imidazoquinoline-conjugated degradable coacervate conjugate for local cancer immunotherapy (2020) ACS BIOMATERIALS SCIENCE & ENGINEERING. 6(9). p.4993-5000
- The opposing effect of type I IFN on the T cell response by non-modified mRNA-lipoplex vaccines Is determined by the route of administration (2020) MOLECULAR THERAPY-NUCLEIC ACIDS. 22. p.373-381
- Potent and prolonged innate immune activation by enzyme-responsive imidazoquinoline TLR7/8 agonist prodrug vesicles (2020) JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 142(28). p.12133-12139
- Chlamydia : what is on the outside does matter (2020) CRITICAL REVIEWS IN MICROBIOLOGY. 46(1). p.100-119
- 2019
- Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer (2019) FRONTIERS IN IMMUNOLOGY. 10.
- Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine (2019) VACCINES. 7(3).
- Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 Agonists (2019) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 58(43). p.15390-15395
- Improving the repeatability and efficacy of intradermal electroporated self-replicating mRNA (2019) MOLECULAR THERAPY-NUCLEIC ACIDS. 17. p.388-395